, a biotechnology company using the discovery and development of epigenetic markers in the pharmaceutical and biotech industries, is set to present at the China BIO Partnering Forum today in Shanghai.
The company’s Chief Scientific Officer Dr. Alexandre Akoulitchev will be hosting the talk, titled “EpiSwitch™ Biomarkers: Practical Applications For Predictive, Prognostic And Diagnostic Patient Stratifications."
The validated EpiSwitch™ biomarker applications, the focus of the presentation, have demonstrated “high efficacy in predictive, prognostic and diagnostic patient stratifications for lung, haematological, prostate, thyroid and skin cancers.”
Off this cutting edge biotechnology, the company has finalized its fifth collaboration agreement with “leading pharmaceutical companies” to develop biomarkers that can be predictive for immuno-oncology therapeutics.
Dr. Akoulitchev commented: "We are looking forward to establishing new partnerships for OBD's EpiSwitch™ technology in China.
Our experience includes working with American and European biopharmaceutical partners to enable precision medicine initiatives through the incorporation of our proprietary, epigenetic-based biomarker platform across the research and development value chain.”
For more news and updates on Oxford BioDynamics:
Tlou's Managing Director, Mr Tony Gilby said “The Company will now progress with additional work on the ground to deliver a Gas-to-Power solution that can bring significant benefits to the country and to our shareholders. I look forward to updating the market as we continue to develop the project."
Tone Goh, Executive Chairman of GST, commented: "The Company is delighted to have signed this LOI with SIAM. SIAM are one of Thailand's leading business groups and we look forward to working with them to progress this planned data centre project.”
Five financial stories, trending today in a 60 second podcast, including: Google has barred phone maker Huawei off from receiving some updates to the Android operating system, dealing a blow to the Chinese firm and their new smartphones will also lose access to popular Google apps. The move comes after the Trump administration added Huawei to a list of companies that American firms cannot trade with unless they have a licence.
On today's podcast: Glen Goodman author of, "The Crypto Trader", talks about the recent rise, fall and rise again of Bitcoin. Russ Mould covers Stock Spirits, Nichols & Vodafone. Alan Green talks about: Cadence Minerals, RA International & BigDish.
SP Angel research note on commodities and miners, featuring: Anglo Asian Mining* (AAZ LN) BUY – 126p – Earnings update African Battery Metals* (ABM LN) – Kisinka copper-cobalt project field programme completed BlueRock Diamonds* (BRD LN) – Funding raised to implement new mine plan Pan African Resources (PAF LN) – Q3 results on track to meet guidance of 170,000oz of gold production